Carregant...
Clinical challenges associated with bortezomib therapy in multiple myeloma and Waldenströms Macroglobulinemia
Rapid development of the small molecule proteasome inhibitor bortezomib has yielded important clinical benefit for patients with multiple myeloma. Early phase clinical trials suggest the agent has similar efficacy in Waldenströms Macroglobulinemia. Optimization of bortezomib-based therapy, though, r...
Guardat en:
| Autors principals: | , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2009
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3133638/ https://ncbi.nlm.nih.gov/pubmed/19452315 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/10428190902866732 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|